Olaiz-Fernández G, Rojas R, Aguilar-Salinas CA, Rauda J, Villalpando S

Language: Spanish
References: 24
Page: 331-337
PDF size: 166.89 Kb.

ABSTRACT

Objective. To show the prevalence of diabetes mellitus (DM) and its associated factors in adults, using data derived from the 2000 National Health Survey (NHS). Material and Methods. The 2000 NHS was conducted between November 1999 and June 2000. An adult questionnaire was administered to 45 294 subjects 20 years of age and older. Capillary glucose levels, weight, height and blood pressure were obtained. Individual weighted factors were considered in the statistical analysis, as was the survey’s complex sampling design to obtain variances using SUDAAN 7.5.6. Results. The national prevalence of DM in adults ages 20 years and older was 7.5% (95% CI: 7.1-7.9). The prevalence was 7.8% in women and 7.2% in men. It was higher according to age: 2.3% in adults 40 years or younger and 21.2% in those older than 60 years of age. In the urban population, prevalence was 8.1% and in the rural population it was 6.5%. The disease was more frequent in the northern region of the country (8.4%) and in the Mexico City metropolitan area (8.1%). DM was more frequent in the population with the least amount of schooling (9.9%), the lowest income (8.1%), high blood pressure (13.7%), hypercholesterolemia (23.3%) microalbuminuria (15.5%) and renal disease (12.3%). Using multivariate logistic regression, stratified by gender, variables associated with DM were identified: age, little schooling, family history of DM, high blood pressure, renal disease or hypercholesterolemia in both genders. Abdominal obesity was associated with DM in women only and living in an urban area was associated with DM only in men. The highest associations were observed with age, family history of DM, and microalbuminuria. Conclusion. Results from the 2000 NHS show that DM represents a serious public health problem in Mexico. The impact increases when DM affects populations with social or economic factors that limit access to treatment. Data reported in this paper are useful to the implementation of screening and prevention programs. These results confirm that DM should be screened in first-degree family members and everyone who has one or more metabolic syndrome components (high blood pressure, dyslipidemia, obesity and microalbuminuria).

REFERENCES

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;4141:782-778.

2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053.

3. Aguilar-Salinas CA, Vázquez-Chávez C, Gamboa-Marrufo R, García-Soto N, Ríos-González JJ, Holguín R, et al Prevalence of obesity, diabetes, hypertension and tobacco consumption in an urban adult mexican population. Arch Med Res 2001;32:446-453.

4. Posadas-Romero C, Yamamoto-Kimura L, Lerman-Garber I, Zamora-González J, Fajardo-Gutiérrez A, Velázquez L, et al. The prevalence of NIDDM and associated coronary risk factors in Mexico City. Diabetes Care 1994;17(12):1441-1448.

5. Lerman-Garber I, Rull-Rodrigo JA. Epidemiology of diabetes in Mexico and associated coronary risk factors. Isr Med Assoc J 2001;3(5):369-373.

6. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025. Diabetes Care 1998;21:1414-1431.

7. Secretaría de Salud (SSA). Compendio Histórico. Estadísticas Vitales 1893-1995.

8. Secretaría de Salud. Estadísticas de mortalidad en México: muertes registradas en el año 2000. Salud Publica Mex 2002;44:266-282.

9. Secretaría de Salud. Estadísticas de mortalidad en México: muertes registradas en el año 2001. Salud Publica Mex 2002;44:565-581.

10. Secretaría de Salud. Estadísticas de mortalidad en México: muertes registradas en el año 2002. Salud Publica Mex 2004;46:169-185.

11. Secretaría de Salud. Estadísticas de mortalidad en México: muertes registradas en el año 2003. Salud Publica Mex 2005;47:171-187.

12. Secretaría de Salud. Morbilidad 1984-2002 en México. Versión en CD.

13. Secretaría de Salud. Estadística de egresos hospitalarios de la Secretaría de Salud 2000. Salud Pública Mex 2001;43:494-510.

14. Aguilar-Salinas CA, Mehta R, Rojas R, Gómez-Pérez FJ, Obiz G, Rull JA. Management of the metabolic syndrome as a strategy for preventing the macrovascular complications of type 2 diabetes: controversial issues. Curr Diab Rev 2005;1:145-158.

15. Dirección General de Estadística. VII Censo General de Población, 1950. México, DF: Instituto Nacional de Geografía, Estadística e Informática. 1953.

16. Instituto Nacional de Estadística, Geografía e Informática. XII Censo Nacional de Población. Tabulados Básicos Tomo I. México: INEGI, 2001.

17. Aguilar-Salinas CA. Promoción de la salud para la prevención de las enfermedades crónico-degenerativas vinculadas con la alimentación y el estilo de vida. En: García-Viveros M, ed. Salud comunitaria y promoción de la salud. España: ICEPSS, 1999.

18. Sánchez-Castillo CP, Lara JJ, Villa AR, Aguirre J, Escobar M, Gutiérrez H, et al. Related articles, unusually high prevalence rates of obesity in four mexican rural communities. Eur J Clin Nutr 2001;55(10):833-840.

19. Valdespino JL, Olaiz G, López-Barajas MP, Mendoza L, Palma O, Velásquez O, et al. Encuesta Nacional de Salud 2000. Tomo I, Vivienda, población y utilización de servicios. Cuernavaca, Morelos, México: Instituto Nacional de Salud Pública, 2003.

20. Habith JP. Estandarización de métodos epidemiológicos cuantitativos sobre el terreno. PAHO Bull 1974;76:375-384.

21. Lohman TG, Roche AF, Martorell R, ed. Anthropometric standardization reference manual. Champaing, Illinois: Human Kinetics Books, 1988.

22. Olaiz G, Rojas R, Barquera S, Shamah T, Aguilar C, Cravioto P, et al. Encuesta Nacional de Salud 2000. Tomo 2, La salud de los adultos. Cuernavaca, Morelos, México: Instituto Nacional de Salud Pública, 2003.

23. Jury DR, Mikkelsen DJ, Glen D, Dunn PJ. Assessment of Micral-Test microalbuminuria test strip in the laboratory and in diabetic outpatients. Ann Clin Biochem 1992;29(Pt 1):96-100.

24. Clinical Guidelines on the Identification. Evaluation and treatment of Overweight and Obesity in Adults. Bethesda, MD: National Institutes of Health, 1998.